earnings
confidence high
sentiment positive
materiality 0.75
Amgen Q3: GAAP EPS $3.98, non-GAAP $4.70; revenue $6.7B (-1%); volumes +8%; FY22 rev guide $26.0-26.3B
AMGEN INC
2022-Q3 EPS reported
$9.11
revenue$19,484,000,000
- GAAP EPS $3.98 (up from $3.31); non-GAAP EPS $4.70 (up from $4.08).
- Total revenues $6.7B, down 1% YoY; product sales volumes grew 8%, offset by 5% lower net price and 2% FX headwind.
- Free cash flow $2.8B in Q3 versus $2.2B in prior year.
- FY 2022 revenue guidance revised to $26.0-26.3B; GAAP EPS $11.46-12.17; non-GAAP EPS $17.25-17.85.
- Non-GAAP policy changed: upfront license fees no longer excluded; Q3 2021 non-GAAP EPS recast downward by $0.59.